From February 25, 2022 to March 7, 2022, the company has repurchased 40,323 shares, representing 0.23% for KRW 547.51 million. With this, the company has completed the repurchase of 40,323 shares, representing 0.23% for KRW 547.51 million under the buyback announced on February 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,915 KRW | -0.36% | +1.06% | -8.37% |
1st Jan change | Capi. | |
---|---|---|
-8.37% | 51.99M | |
-3.33% | 249B | |
+10.09% | 18.86B | |
0.00% | 17.37B | |
-1.32% | 10.65B | |
-7.73% | 10.26B | |
+3.86% | 6.72B | |
+9.76% | 5.94B | |
-0.06% | 4.55B | |
-16.98% | 3.83B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Tranche Update on Icure Pharmaceutical Incorporation's Equity Buyback Plan announced on February 25, 2022.